28th May 2025 07:00
TRISTEL plc
("Tristel" or the "Company")
Conference attendance at Mello2025 Investor event
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting and exhibiting at the Mello2025 investor event on Tuesday 3 June 2025, which will be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY.
Matt Sassone, CEO of Tristel plc, will be presenting at 10:10am (BST) and 14:05pm (BST) on the day providing an overview of the Company and strategy. No new information will be disclosed at the event and a PDF of the presentation will be made available on the Company's website at https://investors.tristel.com/investor-hub/
For further information and tickets for the Mello2025 conference, please visit the event website at www.melloevents.com/mello2025.
For further information please contact:
Tristel plc | Via Walbrook PR | ||
Matt Sassone, Chief Executive Officer | www.investors.tristel.com | ||
Liz Dixon, Chief Financial Officer | |||
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | ||
Paul McManus / Lianne Applegarth / Alice Woodings | Mob: 07980 541 893/ 07584 391 303/ 07407 804 654 | ||
Cavendish Capital Markets Ltd | Tel: 020 7220 0500 | ||
Geoff Nash / Trisyia Jamaludin (Corporate Finance) | |||
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) | |||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
Related Shares:
Tristel